General Surgery (East Africa)
Introduction: Fibrolamellar carcinoma (FLC) is a rare pathologically distinct primary liver cancer. Surgical resection is the only treatment associated with prolonged survival. Trans-arterial embolization (TAE), which is a recognised treatment for hepatocellular carcinoma has been used to treat FLC. We present a case and performed a literature review of patients with FLC treated with TAE.
Case presentation: We present a 19-year old female with a large potentially resectable FLC which was initially treated with trans-arterial chemo-embolization (TACE) with drug eluting beads. The TACE was followed by surgical resection. Histology confirmed tumour necrosis related to the previous TACE.
Discussion & literature review: We identified seven case reports and one case series of TAE for FLC. TAE was either used as a neo-adjuvant therapy to facilitate subsequent tumour resection or as a palliative treatment modality. We propose an algorithm for the treatment of FLC that includes TAE.
Conclusion: The rarity of FLC and the paucity of data precludes establishing clear evidence-based standards of care. We propose an algorithm for the treatment of FLC. The establishment of an international registry may facilitate the collection of better quality evidence.
International Journal of Surgery Case Reports
Bernon, M. M.,
(2022). Trans-arterial therapy for Fibrolamellar carcinoma: A case report and literature review. International Journal of Surgery Case Reports, 94(106980), 1-5.
Available at: https://ecommons.aku.edu/eastafrica_fhs_mc_gen_surg/68
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.